Application of the Gradient Boosted Method in Randomised Clinical Trials: Participant Variables That Contribute to Depression Treatment Efficacy of Duloxetine, SSRIs or Placebo

Journal of Affective Disorders - Netherlands
doi 10.1016/j.jad.2014.05.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Trajectories of Depression Severity in Clinical Trials of Duloxetine

Archives of General Psychiatry
2011English

A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease

PLoS ONE
Multidisciplinary
2013English

The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials

Lung
PulmonaryRespiratory Medicine
2019English

The Test-Negative Design: Validity, Accuracy and Precision of Vaccine Efficacy Estimates Compared to the Gold Standard of Randomised Placebo-Controlled Clinical Trials

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2013English

SSRIs Start to Relieve Depression Soon After the Start of Treatment

BMJ
2006English

Bayesian Modelling and ROC Analysis to Predict Placebo Responders Using Clinical Score Measured in the Initial Weeks of Treatment in Depression Trials

British Journal of Clinical Pharmacology
Pharmacology
2007English

Even More Suicide Attempts in Clinical Trials With Paroxetine Randomised Against Placebo

BMC Psychiatry
PsychiatryMental Health
2006English

Randomised, Double Blind, Placebo Controlled Clinical Trial of Efficacy of Vitamin a Treatment in Non-Measles Childhood Pneumonia

BMJ
1997English

Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study

Journal of Affective Disorders
PsychiatryClinical PsychologyMental Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy